Naringenin alleviates bone cancer pain in rats via down-regulating spinal P2X7R /PI3K/AKT signaling: involving suppression in spinal inflammation
ConclusionNAR alleviated BCP through inhibiting inflammatory cytokines and down-regulating P2X7R/PI3K/AKT signaling in the spinal cord of rats. These findings revealed that NAR, as an effective agent against BCP, may provide an effective approach in the management of bone cancer patients.Graphic abstract
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research
More News: Back Pain | Bone Cancers | Cancer | Cancer & Oncology | Cytology | Pain | Pain Management | Study | Toxicology